Cargando…
ESCMID COVID-19 living guidelines: drug treatment and clinical management: author's reply
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744251/ https://www.ncbi.nlm.nih.gov/pubmed/35026374 http://dx.doi.org/10.1016/j.cmi.2021.12.025 |
_version_ | 1784630078832902144 |
---|---|
author | Bartoletti, Michele Azap, Ozlem Barac, Aleksandra Bussini, Linda Ergonul, Onder Krause, Robert Martín-Quirós, Alejandro Paño-Pardo, José Ramon Power, Nicholas Sibani, Marcella Szabo, Balint Tsiodras, Sotirios Zollner-Schwetz, Ines Rodriguez-Baño, Jesús |
author_facet | Bartoletti, Michele Azap, Ozlem Barac, Aleksandra Bussini, Linda Ergonul, Onder Krause, Robert Martín-Quirós, Alejandro Paño-Pardo, José Ramon Power, Nicholas Sibani, Marcella Szabo, Balint Tsiodras, Sotirios Zollner-Schwetz, Ines Rodriguez-Baño, Jesús |
author_sort | Bartoletti, Michele |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8744251 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87442512022-01-10 ESCMID COVID-19 living guidelines: drug treatment and clinical management: author's reply Bartoletti, Michele Azap, Ozlem Barac, Aleksandra Bussini, Linda Ergonul, Onder Krause, Robert Martín-Quirós, Alejandro Paño-Pardo, José Ramon Power, Nicholas Sibani, Marcella Szabo, Balint Tsiodras, Sotirios Zollner-Schwetz, Ines Rodriguez-Baño, Jesús Clin Microbiol Infect Letter to the Editor European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022-04 2022-01-10 /pmc/articles/PMC8744251/ /pubmed/35026374 http://dx.doi.org/10.1016/j.cmi.2021.12.025 Text en © 2022 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Bartoletti, Michele Azap, Ozlem Barac, Aleksandra Bussini, Linda Ergonul, Onder Krause, Robert Martín-Quirós, Alejandro Paño-Pardo, José Ramon Power, Nicholas Sibani, Marcella Szabo, Balint Tsiodras, Sotirios Zollner-Schwetz, Ines Rodriguez-Baño, Jesús ESCMID COVID-19 living guidelines: drug treatment and clinical management: author's reply |
title | ESCMID COVID-19 living guidelines: drug treatment and clinical management: author's reply |
title_full | ESCMID COVID-19 living guidelines: drug treatment and clinical management: author's reply |
title_fullStr | ESCMID COVID-19 living guidelines: drug treatment and clinical management: author's reply |
title_full_unstemmed | ESCMID COVID-19 living guidelines: drug treatment and clinical management: author's reply |
title_short | ESCMID COVID-19 living guidelines: drug treatment and clinical management: author's reply |
title_sort | escmid covid-19 living guidelines: drug treatment and clinical management: author's reply |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744251/ https://www.ncbi.nlm.nih.gov/pubmed/35026374 http://dx.doi.org/10.1016/j.cmi.2021.12.025 |
work_keys_str_mv | AT bartolettimichele escmidcovid19livingguidelinesdrugtreatmentandclinicalmanagementauthorsreply AT azapozlem escmidcovid19livingguidelinesdrugtreatmentandclinicalmanagementauthorsreply AT baracaleksandra escmidcovid19livingguidelinesdrugtreatmentandclinicalmanagementauthorsreply AT bussinilinda escmidcovid19livingguidelinesdrugtreatmentandclinicalmanagementauthorsreply AT ergonulonder escmidcovid19livingguidelinesdrugtreatmentandclinicalmanagementauthorsreply AT krauserobert escmidcovid19livingguidelinesdrugtreatmentandclinicalmanagementauthorsreply AT martinquirosalejandro escmidcovid19livingguidelinesdrugtreatmentandclinicalmanagementauthorsreply AT panopardojoseramon escmidcovid19livingguidelinesdrugtreatmentandclinicalmanagementauthorsreply AT powernicholas escmidcovid19livingguidelinesdrugtreatmentandclinicalmanagementauthorsreply AT sibanimarcella escmidcovid19livingguidelinesdrugtreatmentandclinicalmanagementauthorsreply AT szabobalint escmidcovid19livingguidelinesdrugtreatmentandclinicalmanagementauthorsreply AT tsiodrassotirios escmidcovid19livingguidelinesdrugtreatmentandclinicalmanagementauthorsreply AT zollnerschwetzines escmidcovid19livingguidelinesdrugtreatmentandclinicalmanagementauthorsreply AT rodriguezbanojesus escmidcovid19livingguidelinesdrugtreatmentandclinicalmanagementauthorsreply AT escmidcovid19livingguidelinesdrugtreatmentandclinicalmanagementauthorsreply |